trihexyphenidyl has been researched along with Thalassemias in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Storrie, MC | 1 |
| Scher, M | 1 |
| McGuire, J | 1 |
| Bokan, J | 1 |
1 other study available for trihexyphenidyl and Thalassemias
| Article | Year |
|---|---|
Thrombocytopenia in the absence of leukopenia associated with the use of neuroleptics.
Topics: Adult; Benztropine; Chlorpromazine; Haloperidol; Humans; Male; Perphenazine; Schizophrenia; Thalasse | 1978 |